Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers

BACKGROUND: Breast cancers (BC) in women carrying mutations in BRCA1 gene are more frequently estrogen receptor negative than the nonhereditary BC. Nevertheless, tamoxifen has been found to have a protective effect in preventing contralateral tumors in BRCA1 mutation carriers. The identification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Litwiniuk, Maria M, Rożnowski, Krzysztof, Filas, Violetta, Godlewski, Dariusz D, Stawicka, Małgorzata, Kaleta, Remigiusz, Bręborowicz, Jan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387169/
https://www.ncbi.nlm.nih.gov/pubmed/18405391
http://dx.doi.org/10.1186/1471-2407-8-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387169/
https://www.ncbi.nlm.nih.gov/pubmed/18405391
http://dx.doi.org/10.1186/1471-2407-8-100

Ejemplares similares